Ronald W. Kim-RONKIMLAW served in the United States Navy from 1970 through 1972. Mr. Kim attended the University of Florida and received his Bachelor of Science in Business Administration with a major in Accounting, and attended the University of Memphis School of Law and received his Juris Doctor in 1980.
Mr.Ronald W. Kim is the owner of the Memphis based law firm of RON KIM LAW, an Association of Trial Lawyers and has offices in Tennessee and Alabama. His legal practice focuses on injury, business, and intellectual property, biotech and health law matters. Mr. Kim is admitted to practice in Tennessee and Alabama courts. Ronald W. Kim is a member of the Tennessee Bar Association including the sections of Alternative Dispute Resolution and Health Law, Memphis Shelby County Bar Association, including the section of Alternative Dispute Resolution, Florida Bar Association and Alabama Bar Association.
Mr. Ronald W. Kim is admitted to practice in the following federal courts: United States Tax Court, United States District Court Northern District of Mississippi, United States District Court Western and Middle Districts of Tennessee and the United States District Court Northern District of Florida, United States District Court, Eastern and Western Districts of Arkansas. Mr. Kim is a Tennessee Supreme Court Rule 31 Civil Mediator and is a principal of ADRI, LLC, see, www.adrinst.com.
Mr.Ronald W. Kim has a number of years of experience defending individuals and insurance carriers with respect to personal injury claims. He has litigated to judgment and/or settled thousands of cases representing injured parties. In addition he has litigated or resolved intellectual property matters, including but not limited to those dealing with confidentiality and non-compete clauses.
Mr. Ronald W. Kim was a co-founder of the Biotech Company, Viral Antigens Inc., and was in-house counsel for that Company for many years. Viral Antigens Inc. was subsequently purchased by a public company, Meridian BioSciences, Inc.
Mr.Ronald W. Kim is well versed in intellectual property law and has negotiated complex contracts for the production of early phase vaccines and has negotiated biotechnology manufacturing and licensing agreements with private and public pharmaceutical and diagnostics companies worldwide. www.ronkimlaw.com